EUVIMEDEUVIMED entdecken
Crossref

A Point-of-Care High-Throughput Biosensing System of Home Monitoring for CRC Postoperative Recurrence by Detecting CEA, MicroRNA-21, and IL-6

Huimin Li, Zhixiang Liang, Qi Meng, Junlei Han, Zuokun Yin, Zhipeng Xu, Xinyu Li, Jun Chen, Li Wang

IEEE Transactions on Biomedical Engineering · 2026-10 · 73 (10) · 3522-3530

DOI: 10.1109/tbme.2026.3654630 ↗

Kurz gefasst

Fachartikel in der Zeitschrift IEEE Transactions on Biomedical Engineering, 2026-10. Verfasst von Huimin Li und 8 weiteren Autor:innen. Hauptthemen laut MEDLINE: MicroRNAs, Carcinoembryonic Antigen, Interleukin-6, Biosensing Techniques. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key R&D Program of Shandong Province, Innovation Team of Organ-on-a-Chip Manufacturing Key Technologies.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Approximately 30% of stage II and 70% of stage III colorectal cancer (CRC) patients suffer postoperative recurrence owing to delayed diagnosis. However, existing diagnostic approaches, particularly electrochemical biosensors, face challenges including poor diagnostic accuracy in single-biomarker analysis, cross-reactivity in multiplex detection, and the absence of long-term home monitoring device. METHODS: This study introduced a portable point-of-care testing (POCT) biosensing system integrating a 256-channel microelectrode array (MEA) sensor for at-home detection of CRC recurrence biomarkers-carcinoembryonic antigen (CEA), microRNA-21 (miR-21), and interleukin-6 (IL-6). RESULTS: These sensors exhibited ultra-high sensitivity of 21.47 nA/lg(ng/mL), 26.50 nA/lg(pM), 15.72 nA/lg(ng/mL) for CEA, miR-21, and IL-6. Clinical validation showed strong concordance with conventional assays (ELISA and RT-qPCR), with correlation coefficients of 0.9809, 0.9998, and 0.9950.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsCarcinoembryonic AntigenInterleukin-6Biosensing TechniquesColorectal NeoplasmsPoint-of-Care SystemsNeoplasm Recurrence, LocalHumansBiomarkers, TumorEquipment DesignSensitivity and Specificity

Substanzen

MicroRNAsCarcinoembryonic AntigenInterleukin-6MIRN21 microRNA, humanBiomarkers, Tumor

Förderung

  • National Natural Science Foundation of China
  • Key R&D Program of Shandong Province
  • Innovation Team of Organ-on-a-Chip Manufacturing Key Technologies
  • Jinan Science and Technology Bureau
  • Shandong Provincial Natural Science Foundation
  • Qilu University of Technology
  • Education and Industry Integration

Zitieren

APA

Li, H., Liang, Z., Meng, Q., Han, J., Yin, Z., Xu, Z., Li, X., Chen, J., & Wang, L. (2026). A Point-of-Care High-Throughput Biosensing System of Home Monitoring for CRC Postoperative Recurrence by Detecting CEA, MicroRNA-21, and IL-6. IEEE Transactions on Biomedical Engineering, 73(10), 3522-3530. https://doi.org/10.1109/tbme.2026.3654630

Vancouver

Li H, Liang Z, Meng Q, Han J, Yin Z, Xu Z, et al. A Point-of-Care High-Throughput Biosensing System of Home Monitoring for CRC Postoperative Recurrence by Detecting CEA, MicroRNA-21, and IL-6. IEEE Transactions on Biomedical Engineering. 2026;73(10):3522-3530. doi:10.1109/tbme.2026.3654630

BibTeX
@article{Li2026,
  author = {Li, Huimin and Liang, Zhixiang and Meng, Qi and Han, Junlei and Yin, Zuokun and Xu, Zhipeng and Li, Xinyu and Chen, Jun and Wang, Li},
  title = {A Point-of-Care High-Throughput Biosensing System of Home Monitoring for CRC Postoperative Recurrence by Detecting CEA, MicroRNA-21, and IL-6},
  journal = {IEEE Transactions on Biomedical Engineering},
  year = {2026},
  volume = {73},
  number = {10},
  pages = {3522--3530},
  doi = {10.1109/tbme.2026.3654630}
}
Kostenlos starten →